The International Consortium of Vascular Registries (ICVR) was launched in November 2014 at Cornell University as a partnership of over 12 national registries, the FDA, manufacturers, and other stakeholders. The mission of the International Consortium of Vascular Registries (ICVR) is to provide a collaborative platform through which registries and other stakeholders around the world can share data to improve vascular health care. In order to create this collaborative platform, the ICVR is leveraging existing national registries, including the Society for Vascular Surgery Vascular Quality Initiative (VQI) and a history of collaboration in Vascunet, a “sub-committee of the European Society of Vascular Surgery which aims to increase knowledge and understanding of vascular disease, and to promote excellence in vascular surgery, by means of international vascular audit.” Currently two sets of projects are underway to investigate the safety and efficacy of vascular interventions: IPAP and InVASC. The IPAP project evaluates AAA device performance for Infrarenal AAA Repair and Juxtarenal Aortic Repair. The main focus of the three retrospective InVASC projects is to compare treatment type (open vs. interventional) and patient selection (symptoms, urgency, patient demographics) between and within countries.